151 related articles for article (PubMed ID: 27914515)
1. Measurement of red blood cell eicosapentaenoic acid (EPA) levels in a randomised trial of EPA in patients with colorectal cancer liver metastases.
Watson H; Cockbain AJ; Spencer J; Race A; Volpato M; Loadman PM; Toogood GJ; Hull MA
Prostaglandins Leukot Essent Fatty Acids; 2016 Dec; 115():60-66. PubMed ID: 27914515
[TBL] [Abstract][Full Text] [Related]
2. Randomised, placebo-controlled, phase 3 trial of the effect of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) on colorectal cancer recurrence and survival after surgery for resectable liver metastases: EPA for Metastasis Trial 2 (EMT2) study protocol.
Hull MA; Ow PL; Ruddock S; Brend T; Smith AF; Marshall H; Song M; Chan AT; Garrett WS; Yilmaz O; Drew DA; Collinson F; Cockbain AJ; Jones R; Loadman PM; Hall PS; Moriarty C; Cairns DA; Toogood GJ
BMJ Open; 2023 Nov; 13(11):e077427. PubMed ID: 38030258
[TBL] [Abstract][Full Text] [Related]
3. Anticolorectal cancer activity of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid.
Cockbain AJ; Volpato M; Race AD; Munarini A; Fazio C; Belluzzi A; Loadman PM; Toogood GJ; Hull MA
Gut; 2014 Nov; 63(11):1760-8. PubMed ID: 24470281
[TBL] [Abstract][Full Text] [Related]
4. The omega-3 polyunsaturated fatty acid eicosapentaenoic acid inhibits mouse MC-26 colorectal cancer cell liver metastasis via inhibition of PGE2-dependent cell motility.
Hawcroft G; Volpato M; Marston G; Ingram N; Perry SL; Cockbain AJ; Race AD; Munarini A; Belluzzi A; Loadman PM; Coletta PL; Hull MA
Br J Pharmacol; 2012 Jul; 166(5):1724-37. PubMed ID: 22300262
[TBL] [Abstract][Full Text] [Related]
5. Unsaturated fatty acids differ between hepatic colorectal metastases and liver tissue without tumour in humans: results from a randomised controlled trial of intravenous eicosapentaenoic and docosahexaenoic acids.
Stephenson JA; Al-Taan O; Arshad A; West AL; Calder PC; Morgan B; Metcalfe MS; Dennison AR
Prostaglandins Leukot Essent Fatty Acids; 2013 Jun; 88(6):405-10. PubMed ID: 23647811
[TBL] [Abstract][Full Text] [Related]
6. Eicosapentaenoic acid and aspirin, alone and in combination, for the prevention of colorectal adenomas (seAFOod Polyp Prevention trial): a multicentre, randomised, double-blind, placebo-controlled, 2 × 2 factorial trial.
Hull MA; Sprange K; Hepburn T; Tan W; Shafayat A; Rees CJ; Clifford G; Logan RF; Loadman PM; Williams EA; Whitham D; Montgomery AA;
Lancet; 2018 Dec; 392(10164):2583-2594. PubMed ID: 30466866
[TBL] [Abstract][Full Text] [Related]
7. Changes in plasma chemokine C-C motif ligand 2 levels during treatment with eicosapentaenoic acid predict outcome in patients undergoing surgery for colorectal cancer liver metastasis.
Volpato M; Perry SL; Marston G; Ingram N; Cockbain AJ; Burghel H; Mann J; Lowes D; Wilson E; Droop A; Randerson-Moor J; Coletta PL; Hull MA
Oncotarget; 2016 May; 7(19):28139-50. PubMed ID: 27058904
[TBL] [Abstract][Full Text] [Related]
8. Changes in plasma and erythrocyte omega-6 and omega-3 fatty acids in response to intravenous supply of omega-3 fatty acids in patients with hepatic colorectal metastases.
Al-Taan O; Stephenson JA; Spencer L; Pollard C; West AL; Calder PC; Metcalfe M; Dennison AR
Lipids Health Dis; 2013 May; 12():64. PubMed ID: 23648075
[TBL] [Abstract][Full Text] [Related]
9. Baseline blood levels of omega-3 and depression remission: a secondary analysis of data from a placebo-controlled trial of omega-3 supplements.
Carney RM; Steinmeyer BC; Freedland KE; Rubin EH; Rich MW; Harris WS
J Clin Psychiatry; 2016 Feb; 77(2):e138-43. PubMed ID: 26930527
[TBL] [Abstract][Full Text] [Related]
10. The Pharmacokinetic Profile of a New Gastroresistant Capsule Preparation of Eicosapentaenoic Acid as the Free Fatty Acid.
Scaioli E; Cardamone C; Liverani E; Munarini A; Hull MA; Belluzzi A
Biomed Res Int; 2015; 2015():360825. PubMed ID: 26339608
[TBL] [Abstract][Full Text] [Related]
11. A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomized controlled trial.
Hull MA; Sandell AC; Montgomery AA; Logan RF; Clifford GM; Rees CJ; Loadman PM; Whitham D
Trials; 2013 Jul; 14():237. PubMed ID: 23895505
[TBL] [Abstract][Full Text] [Related]
12. Differences of polyunsaturated fatty acid in patients with colorectal cancer and healthy people.
Wang S; Xie J; Li H; Yang K
J Cancer Res Ther; 2015; 11(2):459-63. PubMed ID: 26148618
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a High Concentrate Omega-3 for Correcting the Omega-3 Fatty Acid Nutritional Deficiency in Non-Alcoholic Fatty Liver Disease (CONDIN).
Tobin D; Brevik-Andersen M; Qin Y; Innes JK; Calder PC
Nutrients; 2018 Aug; 10(8):. PubMed ID: 30127297
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase activity mediates colorectal cancer cell resistance to the omega-3 polyunsaturated fatty acid eicosapentaenoic acid.
Volpato M; Ingram N; Perry SL; Spencer J; Race AD; Marshall C; Hutchinson JM; Nicolaou A; Loadman PM; Coletta PL; Hull MA
Cancer Chemother Pharmacol; 2021 Feb; 87(2):173-184. PubMed ID: 33040178
[TBL] [Abstract][Full Text] [Related]
15. Effects of duration of treatment and dosage of eicosapentaenoic acid and stearidonic acid on red blood cell eicosapentaenoic acid content.
Krul ES; Lemke SL; Mukherjea R; Taylor ML; Goldstein DA; Su H; Liu P; Lawless A; Harris WS; Maki KC
Prostaglandins Leukot Essent Fatty Acids; 2012; 86(1-2):51-9. PubMed ID: 22064208
[TBL] [Abstract][Full Text] [Related]
16. Plasma and erythrocyte uptake of omega-3 fatty acids from an intravenous fish oil based lipid emulsion in patients with advanced oesophagogastric cancer.
Eltweri AM; Thomas AL; Fisk HL; Arshad A; Calder PC; Dennison AR; Bowrey DJ
Clin Nutr; 2017 Jun; 36(3):768-774. PubMed ID: 27342748
[TBL] [Abstract][Full Text] [Related]
17. Red blood cell fatty acid analysis for determining compliance with omega3 supplements in dry eye disease trials.
Gadaria-Rathod N; Dentone PG; Peskin E; Maguire MG; Moser A; Asbell PA
J Ocul Pharmacol Ther; 2013 Nov; 29(9):837-41. PubMed ID: 23971620
[TBL] [Abstract][Full Text] [Related]
18. Effects of Omega-3 Polyunsaturated Fatty Acid Supplementation on Bone Turnover in Older Women.
Dong H; Hutchins-Wiese H; Kleppinger A; Annis K; Liva E; Lammi-Keefe C; Durham H; Feinn R; Kenny AM
Int J Vitam Nutr Res; 2014; 84(3-4):124-32. PubMed ID: 26098476
[TBL] [Abstract][Full Text] [Related]
19. Omega-3 Eicosapentaenoic Acid (EPA) Rich Extract from the Microalga
Rao A; Briskey D; Nalley JO; Ganuza E
Nutrients; 2020 Jun; 12(6):. PubMed ID: 32585854
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
